Boosting Isotretinoin, Outsmarting Botox Resistance & Other Plot Twists
Échec de l'ajout au panier.
Veuillez réessayer plus tard
Échec de l'ajout à la liste d'envies.
Veuillez réessayer plus tard
Échec de la suppression de la liste d’envies.
Veuillez réessayer plus tard
Échec du suivi du balado
Ne plus suivre le balado a échoué
-
Narrateur(s):
-
Auteur(s):
À propos de cet audio
This week, the Derms on Drugs are back with another literature speed-run—think 3D chess meets derm nerd nirvana. We’re answering questions you didn’t even know you had (and a few you wish you didn’t).
Here’s what we’re tackling:
Do herbal supplements turn up dermatomyositis?
Can biologics cut down on blood clots in HS?
Wait… does Claritin supercharge isotretinoin?
Is Sotyktu stirring up rosacea?
How good is the new oral IL-23 inhibitor icotrokinra for psoriasis?
Any fresh weapons against demodex?
Anything new for those stubborn pemphigus oral lesions?
What to do when your patient is resistant to multiple botulinum toxins?
And—holy grail alert—can we actually prevent chemo-induced alopecia in breast cancer?
Pas encore de commentaire